ANVS
ANVS
NYSE · Biotechnology

Annovis Bio

$0.84
+0.10 (+13.16%)
As of Nov 18, 10:10 PM ET ·
ANVS vs Biotechnology Average
Profit Margin
ANVS -27.6%
Avg -192.1%
Rev Growth
ANVS +22.8%
Avg +12.8%

Biotechnology Peers

1013 stocks in sector
Symbol Name Price Change % Market Cap P/E Margin Growth Div Yield Analyst
ANVS Annovis Bio $0.84 +13.16% 39.28M — -27.6% +22.8% — Current
ABBV Abbvie Inc $286.01 -2.33% 520.47B 50.3 6.9% +1.8% 4.47% Strong buy Compare
AMGN Amgen Inc $443.89 -3.07% 252.64B 26.9 21.0% +11.8% 3.21% Hold Compare
GILD Gilead Sciences Inc $168.98 -0.75% 208.95B — 28.9% +2.6% 3.98% Strong buy Compare
VRTX Vertex Pharmaceuticals Inc $536.45 +0.42% 134.82B 33.9 32.9% +10.4% — Strong buy Compare
REGN Regeneron Pharmaceuticals $945.53 -1.28% 98.38B 20.4 31.4% +5.6% — Buy Compare
MRNA Moderna Inc $196.79 -4.84% 90.54B — -145.2% -53.4% — Hold Compare
NTRA Natera Inc $289.50 +0.71% 45.90B — -9.0% +41.1% — Strong buy Compare
RVMD Revolution Medicines Inc $159.82 -1.76% 37.37B — 4.4% +0.4% — Strong buy Compare
BIIB Biogen Inc $251.41 +0.25% 37.21B 107.1 13.1% -0.9% — Buy Compare
ROIV Roivant Sciences Ltd $38.73 +0.05% 28.64B — -3,629.2% -48.7% — Strong buy Compare
INSM Insmed Inc $119.80 -1.69% 25.90B — -210.5% +35.2% — Strong buy Compare
INCY Incyte Corp $117.80 -1.08% 24.53B 60.8 25.0% +14.8% — Hold Compare
UTHR United Therapeutics Corp $577.34 -1.16% 24.15B 19.6 41.9% +18.0% — Strong buy Compare
ALNY Alnylam Pharmaceuticals Inc $149.40 -4.54% 20.98B 7.7 8.5% +53.0% — Strong buy Compare
EXAS Exact Sciences Corp $104.91 +0.95% 20.03B — -6.4% +15.9% — Hold Compare
NBIX Neurocrine Biosciences Inc $162.86 -1.84% 16.90B 24.1 16.7% +24.3% — Strong buy Compare
EXEL Exelixis Inc $68.29 -0.31% 16.88B 19.1 33.7% +12.9% — Hold Compare
BBIO Bridgebio Pharma Inc $78.01 +1.58% 15.27B — -144.4% +86.3% — Strong buy Compare
HALO Halozyme Therapeutics Inc $95.80 -0.18% 11.48B 27.8 22.7% +28.4% — Strong buy Compare
SMMT Summit Therapeutics Inc $10.50 -1.59% 11.32B — 15.4% -3.6% — Buy Compare